ABL Bio
298380.KQ
51.10 USD
-2.50
-4.66%
a
Overview
Last close
51.10 usd
Market cap
2.48B usd
52 week high
60.20 usd
52 week low
14.93 usd
Target price
50.95 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
124.1718
Price/Book Value
25.347
Enterprise Value
2.54B usd
EV/Revenue
126.3066
EV/EBITDA
-32.1061
Key financials
Revenue TTM
20.11M usd
Gross Profit TTM
20.07M usd
EBITDA TTM
-52.25M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
142.99M usd
Net debt
13.42M usd
About
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.
- Symbol298380.KQ
- ExchangeKQ
- IsinKR7298380007
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Sang Hoon Lee Ph.D.
- HeadquarterSeongnam-si
- Web sitehttps://www.ablbio.com
